Location
LSU Health Sciences Center - New Orleans
Event Website
https://www.medschool.lsuhsc.edu/genetics/2023_medical_student_research_poster_symposium.aspx
Presentation Date
23-10-2023 8:30 AM
Description
Neonatal Opioid Withdrawal Syndrome/Neonatal Abstinence Syndrome (NOWS/NAS), resulting from in-utero drug and substance abuse exposure, affects 7 newborns per 1000 live births in the United States. The Modified Finnegan Neonatal Abstinence Scoring System (M-FNASS) has conventionally been employed to monitor and treat NOWS/NAS patients. However, the emerging assessment method known as Eat/Sleep/Console (ESC) has shown promising results in various hospital systems. Recent studies indicate a significant reduction in hospital stays when using the ESC model compared to M-FNASS, accompanied by improvements in other clinically significant outcomes. This study aims to retrospectively gather data from hospitals in the FMOLHS system to investigate whether ESC leads to a significant reduction in hospital stays compared to M-FNASS or other comparable methods.
A retrospective chart review was conducted to collect data on the length of stay (LOS) of NOWS/NAS patients within the FMOLHS hospital system from 2019 to 2022. LOS data from patients assessed using either M-FNASS or ESC were compared, and all statistical analyses were performed using SPSS (version 28). The study included LOS data from a total of 41 patients (21 ESC, 20 M-FNASS). Patients assessed using the ESC method exhibited a substantially lower average LOS of 14.14 days, in contrast to M-FNASS, which had an average LOS of 21.3 days. Further analysis revealed a statistically significant difference between ESC and M-FNASS (p<.001).
The ESC method demonstrated a statistically significant reduction in the average length of stay when compared to M-FNASS for NOWS/NAS patients. These findings align with other studies comparing ESC and M-FNASS and should be considered by healthcare providers when formulating care strategies for NOWS/NAS patients in the future. Adopting the ESC approach has the potential to optimize patient outcomes, mitigate hospitalization costs, and alleviate the burdens faced by affected families.
Recommended Citation
Helm, E Reilly, "Enhancing Care for NOWS/NAS Patients: A ComparativeAnalysis of Eat/Sleep/Console vs. Modified Finnegan Neonatal Abstinence Scoring System and its Impact on Hospital Length of Stay" (2023). Medical Student Research Poster Symposium. 44.
https://digitalscholar.lsuhsc.edu/sommrd/2023MSRD/Posters/44
Included in
Enhancing Care for NOWS/NAS Patients: A ComparativeAnalysis of Eat/Sleep/Console vs. Modified Finnegan Neonatal Abstinence Scoring System and its Impact on Hospital Length of Stay
LSU Health Sciences Center - New Orleans
Neonatal Opioid Withdrawal Syndrome/Neonatal Abstinence Syndrome (NOWS/NAS), resulting from in-utero drug and substance abuse exposure, affects 7 newborns per 1000 live births in the United States. The Modified Finnegan Neonatal Abstinence Scoring System (M-FNASS) has conventionally been employed to monitor and treat NOWS/NAS patients. However, the emerging assessment method known as Eat/Sleep/Console (ESC) has shown promising results in various hospital systems. Recent studies indicate a significant reduction in hospital stays when using the ESC model compared to M-FNASS, accompanied by improvements in other clinically significant outcomes. This study aims to retrospectively gather data from hospitals in the FMOLHS system to investigate whether ESC leads to a significant reduction in hospital stays compared to M-FNASS or other comparable methods.
A retrospective chart review was conducted to collect data on the length of stay (LOS) of NOWS/NAS patients within the FMOLHS hospital system from 2019 to 2022. LOS data from patients assessed using either M-FNASS or ESC were compared, and all statistical analyses were performed using SPSS (version 28). The study included LOS data from a total of 41 patients (21 ESC, 20 M-FNASS). Patients assessed using the ESC method exhibited a substantially lower average LOS of 14.14 days, in contrast to M-FNASS, which had an average LOS of 21.3 days. Further analysis revealed a statistically significant difference between ESC and M-FNASS (p<.001).
The ESC method demonstrated a statistically significant reduction in the average length of stay when compared to M-FNASS for NOWS/NAS patients. These findings align with other studies comparing ESC and M-FNASS and should be considered by healthcare providers when formulating care strategies for NOWS/NAS patients in the future. Adopting the ESC approach has the potential to optimize patient outcomes, mitigate hospitalization costs, and alleviate the burdens faced by affected families.
https://digitalscholar.lsuhsc.edu/sommrd/2023MSRD/Posters/44
Comments
Mentors: Drs. Brian Tran, Cydney Fondel, Mikki Bouquet, and J. Hunter Collins Our Lady of the Lake Children’s Hospital, Baton Rouge, LA